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Abstract: Oral drug administration to pediatric patients is characterized by a lack of age-appropriate
drug products and the off-label use of medicines. However, drug administration practices at hospital
wards is a scarcely studied subject. The aim of this study was to explore the oral drug administration
practices at pediatric hospital wards, with a focus on experiences and challenges faced, methods
used to mitigate existing problems, drug manipulation habits, perceptions about oral dosage forms
and future needs of oral dosage forms for children. This was a qualitative study consisting of
focus group discussions with physicians, nurses and clinical pharmacists in a tertiary university
hospital with the objective of bringing forward a holistic view on this research topic. These healthcare
professionals recognized different administration challenges that were classified as either dosage
form-related or patient-related ones. A lack of depot formulations developed especially for children
as well as oral pediatric dosage forms of drug substances currently available as intravenous dosage
forms was recognized. The preferred oral dosage forms were oral liquids and orodispersible tablets.
Patient-centered drug administration practices including factors facilitating drug administration
both at hospital wards and at home after patient discharge were identified. Among all healthcare
professionals, the efficient cooperation in drug prescribing and administration as well as in educating
the child’s caregivers in correct administration techniques before discharge and improving the overall
discharge process of patients was emphasized. This study complements the prevalent understanding
that new dosage forms for children of varying ages and stages of development are still needed. It also
brings a holistic view on different aspects of oral drug administration to pediatric patients and overall
patient-centered drug administration practices.
Keywords: oral drug administration; drug administration challenges; qualitative study; pediatric;
drug manipulation; age-appropriate
1. Introduction
Oral administration to pediatric patients is characterized by a lack of age-appropriate drug
products and the off-label use of medicines. This off-label use implies that the indication or route
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of administration differs from the summary of Product Characteristics (SPC), the use in pediatrics
is contraindicated or that the age or weight of the patient is below the specifications in SPC. In a
study conducted in Swedish hospitals, 60 percent of hospitalized children had at least one medicine
prescribed off-label [1]. The off-label use of medicines was most common for neonates and infants.
Recently, the off-label use of medicines to children has been addressed on a European level as the
European Academy of Pediatrics and the European Society for Developmental Perinatal and Pediatric
Pharmacology published a statement on recommendations on the appropriate, rational and safe
prescribing of off-label medicines to pediatric patients [2]. The lack of age-appropriate medicines is
also generating the need to physically modify drug products. This manipulation concerns mainly
solid oral dosage forms and is done to enable the administration of an appropriate dose or enhance
medicine administration [3,4]. The typical methods for manipulating solid dosage forms are the
splitting and crushing of tablets, opening of capsules and dispersing powder in liquid or food [4].
Drug administration through enteral feeding tubes is also related to the dispersion of solid dosage
forms [5]. Recommendations considering the risk of physical blockage of the feeding tube as well as
the chemical compatibility of a drug product with the tube material have been published by European
Medicines Agency (EMA) in a guideline on pharmaceutical development of medicines for children [6].
Such events would affect the administered drug amount; however, potential drug loss can be shown
by mimicking drug administration through enteral feeding tubes for children [5,7].
The ideal orally administered formulation for children would enable flexible dosing, be palatable
and easy to administer, contain only child-safe excipients and be stable from microbiological, physical
and chemical perspectives [8]. Flexible dosing is often linked to liquid dosage forms, multi-particulate
formulations and mini-tablets, whereas solid dosage forms are associated with good stability [9]. A risk
of exposure to excipients through the oral administration route exists, since excipients are used in oral
dosage forms to improve, for instance, patient acceptability, the solubility of the drug substance or the
shelf-life of the drug product [10]. Excipients such as preservatives, colorants, sweeteners, ethanol and
propylene glycol can be harmful to children, especially for infants and neonates [10–12]. Garcia-Palop
et al. discovered in a Spanish University Hospital that at least one harmful excipient was present in
62% of orally administered drugs used for neonates [13]. Further observations revealed that excipient
amounts exceeded the recommendations for maximum daily intake for adults in 19% of oral medicines.
Additionally, a Danish study showed that the exposure of benzyl alcohol, ethanol and propylene glycol
in hospitalized neonates and infants less than 2 years of age was substantial and the cumulative daily
exposure frequently exceeded the tolerance limits stated by EMA [14].
The age of pediatric patients was identified as the main aspect influencing the choice of dosage
form [15]. An observational study reviewing oral drug administrations to pediatric inpatients aged
0–15 years over a one-year period showed that a liquid dosage form was used in more than half of all
oral drug administrations [16]. Most often, liquid dosage forms were administered to children younger
than 6 years of age and in more than 40% of drug administrations to schoolchildren (6–11 years).
Solid dosage forms including tablets, capsules, orodispersible and chewable tablets were used in 28%
of the total number of oral drug administrations to children. In children aged 6–17 years and their
caregivers, Ranmal et al., using a questionnaire, assessed attitudes towards choice of six solid dosage
forms (tablets, capsules, mini-tablets, chewable and orodispersible tablets and multiparticulates) [17].
This study evaluated opinions rather than experiences since the investigated dosage forms were not
actually administered to the children, although some children had previously used other solid dosage
forms except for mini-tablets. Among children aged 6–11 years and their caregivers, chewable tablets
were the most favored solid dosage form followed by orodispersible tablets and mini-tablets whereas
tablets and capsules were the least preferred dosage forms. Approximately 80% of adolescents aged
12–17 years found tablets to be the most acceptable dosage form, followed by chewables, orodispersible
tablets and mini-tablets. Recent drug acceptability studies have shown that mini-tablets are well
tolerated by pediatric patients since children aged 6 months to 6 years preferred one placebo-containing
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mini-tablet, having a diameter of 2mm, to glucose syrup [18]. Infants and preschool children were also
able to swallow multiple mini-tablets as one dose [19].
Drug administration practices in hospital wards is a scarcely studied subject. In the past few years,
other working groups have investigated children’s, their caregivers’ and healthcare professionals’
preferences for different oral dosage forms, formulation-related barriers to oral medicine administration
in children as well as execution of oral administrations to hospitalized children [3,15–17,20]. To the
knowledge of the authors, there is only one paper published on healthcare professionals’ opinions
about problems related to prescribing, dispensing and administering oral formulations to children [21].
The aim of this study was to explore the oral drug administration practices at pediatric hospital wards,
with focus on experiences and challenges faced, methods used to mitigate existing problems, drug
manipulation habits, perceptions about oral dosage forms and future needs of oral dosage forms for
children. The objective was to bring a holistic view to the research topic by carrying out this study in
healthcare professionals in a tertiary hospital.
2. Methods
The study was conducted as focus group interviews at a tertiary university hospital. The physicians,
nurses and clinical pharmacists who were invited to participate in the study worked at the Department
of Children and Adolescents, HUS Helsinki University Hospital. The department provides specialized
health care for children ranging from neonates to 15-year-olds in all areas of pediatrics, pediatric surgery,
child neurology and child psychiatry in its catchment area in Southern Finland. In addition, the
department provides care for pediatric patients from across Finland in severe cardiac problems
and organ transplantation, as well as other rare conditions requiring demanding tertiary care.
HUS Pharmacy provides hospital pharmacy services and clinical pharmacists for the Department of
Children and Adolescents.
2.1. Study Design and Data Collection
The qualitative design of focus group discussions was chosen because it is a useful method to
explore the beliefs, behaviors and attitudes of individuals [22]. Themes can evolve both from the
chosen research topics as well as from subjects emerging during the focus group discussions amongst
the participants. In this study, we used an interview guide of semi-structured questions to moderate
the discussion (Table 1). The interview guide was constructed to reflect the study aim and it was tested
in a pilot interview. The interview guide was not altered following the pilot and the pilot interview
was included in the research data. The principal investigator (MR) facilitated the interview sessions
assisted by another investigator (KK). Both investigators have a background in hospital pharmacy.
We used purposive selection of participants in order to get a comprehensive representation of
the different pediatric subspecialties. This type of selection is useful when participants ought to have
something to say about a given topic [22]. Head Physicians of the different pediatric subspecialties
recruited the physicians, a Nurse Director recruited the nurses and the principal investigator (MR)
recruited the clinical pharmacists. The recruitment method was email invitation. The interviews took
place between May and September 2018. Each focus group discussion consisted of participants from
only one profession.
Table 1. Interview guide for the focus group discussions about oral drug administration practices.
Themes
Suitability of orally administered dosage forms to pediatric patients of different age
- benefits
- challenges
- problems and needs for development
Manipulation of drugs prior administration
Risks associated with pharmaceutical excipients
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2.2. Qualitative Analysis
The focus group discussions were digitally audio-recorded and transcribed verbatim. Inductive
content analysis was used to analyze the transcripts utilizing a framework analysis approach.
First, all quotes were identified. The quotes were then coded and codes with a similar meaning
were systematically rearranged into subcategories and categories using Microsoft Excel (Microsoft
Corporation). The transcripts were separately coded and categorized by two investigators (MR and
KK). Any differences in the analysis were discussed until a mutual opinion was reached.
2.3. Ethics and Informed Consent
The Ethics Committee of Helsinki University Hospital granted ethical approval (HUS/3637/2017).
All participants received written information about the study before they gave their written
informed consent.
3. Results
A total of 19 participants were recruited and divided into five groups (Table 2). Each group
consisted of 3–5 participants, all of them having the same profession (physician, nurse or pharmacist).
The focus group discussions lasted for one hour.
Five different themes emerged from the focus group discussions during the coding of the transcripts
(Figure 1). Drug administration challenges were further divided into two subcategories—dosage
form-related and patient-related challenges.Pharmaceutics 2020, 12, 109 5 of 14 
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For these drugs, a need for an orally administered dosage form is apparent. Ketamine, for the 
treatment of pain, vancomycin, midazolam and electrolytes are some examples of intravenous drugs 
also administered orally. 
We use the intravenous dosage form of midazolam because the concentration of the commercial oral 
formulation is so small that we would have to administer a large volume, which is not possible when a child has 
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Taste issues occur especially when intravenous drugs are administered orally and for some liquid 
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Figure 1. Themes arising from the interviews of lt care professionals n oral drug administration
practices in a children’s hospital grouped into categ nd subcategories.
Table 2. Characteristics of the interviewed healthcare professionals in the focus groups.
Variable Physicians (n) Nurses (n) Pharmacists (n)
Gender
Female 4 5 6
Male 4 0 0
Total 8 5 6
Age
20–34 0 1 0
35–49 6 2 5
>50 2 2 1
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3.1. Drug Administration Challenges
Physicians, nurses and clinical pharmacists reported many different administration challenges
(Figure 2).
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3.1.1. Dosage Form-Related Administration Challenges
Tablets and capsules were considered difficult to administer to children. One problem is that the
drug dose in the tablet or capsule is intended for a ults, thus making them unsuitable for children
without modifying the dosage form. Tablets containing multiple active pharmaceutical ingredients
(API), such as medicines against HIV or tuberculosis, are particularly problematic because the required
dose of each API in t e combi ation is dependent on the child’s age.
There are not such tablets available that we would need and then we have to cut or crush or look for other
dosage forms.
Depot tablets or capsules cannot be divided into smaller parts to get the right dose because the
pharmac kinetics of the medicine would change. Thus, it is impossible to give depot formulations
containing unsuitable doses to children even though the medical condition of a child would benefit
from receiving the medicine as a slow release dosage form. Examples of such conditions are pain relief
and treatment of epilepsy. The size of depot formulations is often so big that children cannot swallow
them. Furthermore, it is impossible to crush and admin ster depot formulati ns to p tients that have a
nasogastric tube or percutaneous endoscopic gastrostomies.
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Younger children cannot swallow depot formulations. Depot formulations cannot be administered to older
children withan enteral feeding tube.
The volume of the dose can sometimes be too large for a child to swallow. Liquid formulations
are easy to swallow in general, but if the amount of liquid exceeds a few milliliters, it can result in
spitting or vomiting. The content of the API in the formulation should enable the administration of the
product to different age groups without making the volume of the largest dose too big. An example
of a problematic liquid formulation is oral solutions containing paracetamol. The dose volume often
becomes too big even for infants.
The volume has quite a big impact. If it’s small, it’s much easier to administer than if it’s 5 mL or 10 mL.
Some drugs are available only as formulations for intravenous administration. However, there
are situations when oral administration is the primary route of administration of intravenous drugs.
For these drugs, a need for an orally administered dosage form is apparent. Ketamine, for the
treatment of pain, vancomycin, midazolam and electrolytes are some examples of intravenous drugs
also administered orally.
We use the intravenous dosage form of midazolam because the concentration of the commercial oral
formulation is so small that we would have to administer a large volume, which is not possible when a child
has fasted.
The taste and texture of a drug formulation are important features affecting drug acceptability.
Taste issues occur especially when intravenous drugs are administered orally and for some liquid
formulations. Orally dispersing tablets are challenging for some children because of the texture and
mouth feeling.
A tablet dispersing in the mouth always has a taste and a feeling that a mass remains in the mouth.
Manipulation of dosage forms is widely used to get individual doses and manage swallowing
difficulties. According to the healthcare professionals, techniques such as cutting and crushing of
tablets, emptying of capsules, ex tempore manufacturing of dose powders and liquid formulations, as
well as the dilution of liquid formulations, were applied on a regular basis. The interviews revealed a
concern for dose accuracy related to some drug manipulation practices.
However, if the volume is very small, you get uncertain if the child gets the whole dose and if there is some
loss during the administration.
All focus groups discussed formulation-derived administration challenges. Some patients have
suffered from adverse drug events caused by excipients. A more common administration challenge is,
however, the blockage of the enteral feeding tube because of cellulose-based excipients. The pharmacists
considered ethanol, propylene glycol and parabens potentially harmful to children.
3.1.2. Patient-Related Administration Challenges
Patient-related administration challenges emerging from the data are swallowing, spitting,
vomiting, the need for an enteral feeding tube, age and individual taste preferences (Figure 2).
Swallowing tablets can be challenging for some children regardless of age and size of the tablet. On the
other hand, some children can learn to swallow tablets at a very young age, whereas some adolescents
are not capable of doing it. If a tablet starts melting in the mouth and tastes bad, a normal reaction to
this is spitting. Some infants tend to also spit liquid dosage forms if the volume is larger than 0.5 mL.
For some children, the administration of tablets or big amounts of liquid formulations induces the gag
reflex. The risk for this is more likely the more medicine the child has to swallow at one time or if the
medicine tastes bad. Taste preferences are very individual.
Some children automatically bite the medicine and start tasting it.
Regarding the impact of the age of a child on drug administration challenges, newborns and
infants are the most challenging groups of children. Infants are not accustomed to ingesting anything
other than milk. Some newborns have not even had their first drink of milk before their first oral drug
administration. The need for dose adjustments based on body weight is routine at pediatric wards.
It is also common that these patient groups in particular have an enteral feeding tube.
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Enteral feeding tubes place specific requirements on oral drug administration. All solid oral
dosage forms have to be crushed and dispersed or diluted in fluid before administration. The enteral
feeding tubes must be rinsed with water between administrations of different medicines. Neither the
dispersed solid dosage forms nor the liquid oral dosage forms should cause clogging of the feeding
tubes. If this happens, the tubes must be rinsed with further amounts of water. This can be crucial
when individual fluid restrictions place limitations on the amount of liquid administered to a child.
It is important to consider these requirements in drug development.
The smaller the child, the smaller the tubes and the more easily they clog and then they have to be flushed
and that is truly a significant problem.
3.2. Suitable Dosage Forms for Pediatrics
According to healthcare professionals involved in the focus group discussions, orodispersible
and liquid dosage forms are suitable for most pediatric patients (Table 3). For infants, the liquid
dosage form is easiest to administer. Another benefit is the suitability for dose adjustments, which are
very common as the children grow. For example, ex tempore compounding of a cancer medicine has
improved the adherence and thus the treatment outcomes. A disadvantage of liquid dosage forms is
inferior shelf-life compared to solid dosage forms.
Table 3. Preferred oral dosage forms for children by healthcare professionals.
Dosage Form Citations
Orodispersible
Some children take an orodispersible tablet directly into the mouth, afterwards rinsing with
water or milk
You can give orodispersible tablets to babies who eat purees
Orodispersible tablets are of course probably relatively pleasant to take
Liquid or
suspension
You can administer different doses of oral liquids or suspensions
It is easy to adjust the dose
A liquid is the best alternative for the smallest children
Orodispersible tablets are suitable to administer directly into the mouth or to be dispersed in
a small amount of liquid before administration. Therefore, they were considered to be a good oral
dosage form for children, starting from infants. Solid dosage forms such as tablets and capsules were
only considered suitable for children who can swallow them whole. This ability was not considered to
be connected with any specific age, but rather a completely individual capability.
3.3. Factors Promoting Successful Drug Administration at Hospital Wards
The expertise of nurses plays an important role in managing the successful delivery of oral drugs
(Table 4). It is important to consider the preferences of an individual child when choosing the oral
dosage form and adapting different manipulation techniques. Juices or juice concentrate, milk, fruit
purees or jam are used to cover the bad taste of a drug. The possibility of limiting the total volume of
liquid to be administered directly effects the willingness of the child to take the medication. A useful
aid to facilitate the swallowing of tablets and capsules is covering them with a tasteful coating.
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Table 4. Means to improve medication adherence and successful drug administration.
Professional skills of
the nurse
Skillful administration techniques
Knowledge about useful manipulation methods
Knowledge about the preferences of each individual child
Firm guidance
Manipulation of
drug products
Cutting a tablet into smaller pieces
Crushing of tablets
Covering a bad taste of drug with juice or juice concentrate, glucose solution,
water with added lemon concentrate, milk, fruit purees or jam (especially
raspberry jam is good if the drug is in small pieces)
Ex tempore manufacturing of dose powders from commercial drug products
Dispersing of (crushed) tablets and dose powders before administration
Use of administration aids Coating (Medcoat
®) with good taste to cover the drug and facilitate
swallowing of tablets, as a whole or in halves or pieces, or capsules.
Consulting different
sources of information
Transferring information amongst nurses
Consulting a clinical pharmacist
Consulting the hospital pharmacy
Reading the package information leaflet or summary of product
characteristics
Selecting the most
appropriate drug product
for the child
Ex tempore manufacturing of oral liquids or suspensions
Choosing the more viscous alternative of two liquid formulations
Considering the total volume of liquid formulations to be administered
Using orodispersible tablets and dispersing them with water in a small spoon
Taking into account possible risks with respect to excipients
3.4. Factors Promoting Successful Drug Administration after Patient Discharge
Before patient discharge, a nurse or clinical pharmacist teaches the child’s caregivers how to
administer drug products correctly. Useful drug manipulation techniques as well as drug administration
through an enteral feeding tube, are important to manage completely. Caregivers of severely ill children
are motivated to succeed with drug administration and are able to manage it quite well. However,
there might be language barriers that complicate the education of caregivers.
Sufficient instructions about the handling and administration of medicines must be given at patient discharge.
The availability of uniform drug products and medical supplies in the hospital and at home
facilitates patient discharge and the ability of parents to succeed in drug administration at home. At
the moment, problems occur because both the drug products and medical supplies used in the hospital
differ from the ones the family can buy at a community pharmacy after discharge. For instance, oral
syringes are not available at community pharmacies. It is confusing for parents when the scale on the
syringes differs from the ones used at the training situation. Generic substitution is also confusing for
parents if the tablet bought at the pharmacy looks completely different from the one used at the hospital.
The excipients can also differ, which might lead to differences in solubility and cutting difficulties.
Some physicians forbid generic substitution to avoid these problems.
Oral syringes are used in the hospital but they are not available at community pharmacies. Instructing
parents is therefore problematic since the measuring devices are different.
Syringes used at home should look the same as the ones used in the hospital, differences in scale or color can
be confusing.
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3.5. Roles and Cooperation of Healthcare Professionals
Based on the focus group discussions, different healthcare professionals have different roles in
the drug administration process (Table 5). Physicians prescribe the medication. However, nurses
choose the oral dosage form based on their knowledge about every individual child’s ability to take
medications. Nurses know different ways of managing drug administration challenges and they
inform the physicians on how drug administration may succeed. If problems occur, nurses consult
either the clinical pharmacist or the physician at the ward. Clinical pharmacists give advice on the
choice of dosage form, drug manipulation and the availability of different dosage forms from the
hospital pharmacy.
Table 5. The roles of different healthcare professionals in prescribing and administering oral medicines
at hospital wards.
Profession Role
Physician
Prescribes the active pharmaceutical ingredient, dose and route of
administration. Does not intervene in the choice of dosage form.
Physician and nurse decide the route of administration together
Nurse
Informs physician which oral dosage form an individual child can take
Decides which oral dosage form to administer to the child
Consults physician if problems occur
Knows what gimmicks to use in drug administration
Gives feedback to physician about medication administration
Clinical
pharmacist
Discusses choice of dosage form with nurse
Gives advice in drug manipulation and administration matters
4. Discussion
4.1. Main Findings
Healthcare professionals experience several administration challenges related to oral dosage
forms, as well as the personal features of the patient, including personality and developmental and
health status. Solid oral dosage forms administered to children were connected to swallowing issues
caused by the size of the tablet or capsule and a need for modification of the dosage form in order to
administer a specific dose, facilitate swallowing or administer the drug through an enteral feeding
tube. In this study, typical solutions identified to ease swallowing and mask the taste of the drug
included wrapping capsules, whole tablets or pieces of tablets inside a slippery coating (Medcoat®) or
dispersing crushed tablets, dose powders or the contents of a capsule in juice, juice concentrate or soft
food like fruit pure or jam. Mixing medication with food has also been reported in other studies as a
method to facilitate swallowing and thus improve acceptability [3,20,23].
In this study, both nurses and pharmacists were concerned about the impact of dosage form
manipulations on dose accuracy. Indeed, these concerns are supported by evidence in previous
studies. The splitting of tablets into halves or quarters might result in ununiformed segments regarding
weight or drug content [24–27]. A tablet splitter was shown to be a more reliable method to split
tablets of different sizes and shapes than the use of a kitchen knife, scissors or manual splitting [28].
Cutting tablets into smaller segments presents a risk for over- or under dosing but the clinical impact is
unclear [26,27]. In vitro dissolution studies have shown that orange juice and soft foods such as yoghurt,
honey and jam do not significantly affect the drug release of crushed amlodipine, carbamazepine and
warfarin compared to the dissolution of whole tablets in water [29]. On the other hand, mixing crushed
atenolol with strawberry jam did make the dissolution profile slower. Therefore, avoidance of dosage
form manipulation is recommendable if other suitable dosage forms are available.
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Healthcare professionals seem to prefer oral liquids and orodispersible tablets as the oral dosage
form of choice. Oral liquids were considered to be the most suitable dosage form when administration
into a feeding tube is necessary or there is a need for personalized or flexible doses. However, the
drug concentration of oral liquids should enable flexible administration of different doses without
exceeding a dose volume of a few gulps in order to avoid vomiting and spitting. The manufacturing of
different strengths of oral liquids could solve the challenge of administering a suitable dose volume for
children of varying ages. Similar results were reported by Alyami et al. who identified oral liquids
to be the most preferred dosage form by healthcare professionals, followed by orodispersible tablets,
which were also considered to potentially replace the oral liquids [15].
A lack of depot formulations available for children was recognized especially for the treatment
of pain and epilepsy. A review article by Trofimiuk et al. listed the potential orally administered
modified release formulations for children, of which some are already licensed and others are awaiting
license approval [30]. The off-label administration of intravenous drug formulations orally is another
situation where the treatment options for pediatric patients is not optimal and a need for dosage
form development is obvious. The administration of intravenous formulations orally is common
practice in other countries as well [16,31]. In Australia, chewable chocolate-tasting tablets containing
midazolam showed better acceptability compared to the commonly used intravenous formulation
in a randomized trial involving children receiving premedication before anesthesia [31]. Available
formulations and prevailing practices may differ among hospitals and countries. Although there
has been an increase in the availability of age-appropriate dosage forms for children, most of these
are licensed for use in school-aged children, and the lack of age appropriate dosage forms for the
smaller children prevails. The development of pediatric medicines for a relatively small target group is
however not financially very attractive for pharmaceutical companies. Ex tempore manufacturing of
immediate release formulations is possible on site in hospital pharmacies on-demand but the need for
depot formulations is not an easy task to meet.
Investigations into novel oral dosage forms for children have indicated that formulations such as
orodispersible mini-tablets or films are promising options in pediatric drug development, enabling
personalized and flexible drug administration [7,32]. Dose titrations of enalapril maleate doses in
the range of 0.025–4 mg were manageable with orodispersible mini-tablets of two different strengths
(0.25 and 1 mg, respectively), facilitating flexible dosing for different patient groups [32]. The production
of orodispersible films by means of 2D or 3D printing is considered a possibility for on-demand
manufacturing of patient-specific doses [33,34]. Recently, two different printing technologies were used
to produce orodispersible films containing four different commonly used pediatric doses of warfarin
sodium [7]. It was shown that content uniformity and dose accuracy of the printed orodispersible
films were at least equally good as for dose powders currently used for pediatrics. Both orodispersible
mini-tablets and films dispersed in water were also suitable for administration through a nasogastric
tube without causing blockage of the tube [7,32]. As enteral feeding tubes are widely used in the
hospital setting, it is desirable that tests mimicking administration through feeding tubes for children
are performed during drug development.
Two themes that were not included in the interview guide emerged from the focus group
discussions. One of them was regarding the roles and cooperation of different healthcare professionals
and the other one included the challenges related to patient discharge. Physicians, nurses and
pharmacists had similar opinions about the roles of different healthcare professionals in the prescribing
and administration of drugs. It is evident that when the hospital staff are less experienced with drugs,
clinical pharmacists can have a significant role in clarifying and improving drug administration options
for children. The way collaboration between all these professionals is organized might also be an
important factor, e.g., the clinical pharmacist can give advice about safety and dissolution properties
of excipients and the physician could utilize this information at the time of prescribing. Especially
if a drug is administered through a feeding tube, the possibility of clogging should be considered.
Furthermore, the formulary selection process in the hospital would benefit from multidisciplinary
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cooperation, including expertise on drug administration practices as well as the safe use of excipients
in pediatric patients.
Another phase of care where clinical pharmacists could aid the medication process is patient
discharge. Both nurses and clinical pharmacists discussed the deficiency in availability of similar
syringes for oral administration in community pharmacies as is used at hospital wards. Marketed
pharmaceutical solid formulations containing the same drug substance might differ in their
pharmaceutical properties, such as whether the tablet has a break mark or coating, affecting drug
manipulations and drug administration. Before patient discharge, nurses teach the child’s caregivers
correct drug administration techniques and feeding tube management if needed and the lack of
identical drug products and administration devices might cause confusion and a risk of medication
errors. Both equipment factors and caregiver education have been identified to have an impact on
discharge of pediatric inpatients [35]. Pharmacists at hospitals and in community pharmacies could
cooperate to improve the necessary continuum of uniform drug products and administration devices
after patient discharge from hospital if an impact on medication safety is apparent.
4.2. Strengths and Limitations
Focus group interviews give information about predefined themes as well as topics emerging from
the group discussions. The interview guide was piloted to ensure its functionality. Two investigators
coded the transcripts and analyzed the data independently of each other, which improves the
reliability of the study. Another strength of this study was that several pediatric subspecialties were
represented, although the total amount of participants is usually small in qualitative focus group
studies. The study was conducted at one tertiary pediatric hospital in Finland and the results
cannot be generalized. However, our findings support previous studies conducted in other countries
about oral drug administration to children and bring a holistic view about patient-centered drug
administration practices.
The participants in the focus group discussions were healthcare professionals. Therefore, the
results in this study reflect the experiences and opinions of healthcare professionals and might differ
from the opinions of children themselves or their caregivers. However, the experiences of healthcare
professionals caring for pediatric patients at the wards reflect the behaviors and attitudes of children
during drug administration and give important information on drug administration challenges related
to currently used dosage forms. The opinions of hospitalized pediatric patients and their caregivers on
drug administration challenges should further be investigated.
5. Conclusions
The focus group discussions revealed both challenges, needs and solutions regarding oral drug
administration at hospital wards and information about facilitators to patient discharge. New dosage
forms for children of different ages and developmental stages are needed. The dosage forms should
be flexible to administer in appropriate doses without modifying the drug product. Furthermore,
the size of the solid dosage form or quantity of administered liquid should facilitate swallowing and
medication adherence. The possibility of administering the dose through an enteral feeding tube
should also be kept in mind. The cooperation of different healthcare professionals in drug prescribing
and administration is important, as well as educating the child’s caregivers in correct administration
techniques before patient discharge and improving the overall process of patient discharge.
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